LIPOSOMAL AMPHOTERICIN B (L-AMB) TWICE WEEKLY AS ANTIFUNGAL PROPHYLAXIS IN PEDIACTRIC CANCER PATIENTS

被引：0
|
作者：
Lehrnbecher, Thomas [1 ]
Schedler, Nadine [1 ]
Tramsen, Lars [1 ]
Becker, Martina [1 ]
Klingebiel, Thomas [1 ]
Bochennek, Konrad [1 ]
机构：
[1] Goethe Univ Frankfurt, Frankfurt, Germany
来源：
PEDIATRIC BLOOD & CANCER | 2010年 / 55卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：948 / 949
页数：2
相关论文
共 50 条
  • [1] Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients
    Bochennek, K.
    Tramsen, L.
    Schedler, N.
    Becker, M.
    Klingebiel, T.
    Groll, A. H.
    Lehrnbecher, T.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (12) : 1868 - 1874
  • [2] Pharmacokinetics of a polyene antifungal agent, liposomal amphotericin B (L-AMB), in a severely burned patient
    Sasaki, Junichi
    Matsumoto, Kana
    Fujishima, Seitaro
    Morita, Kunihiko
    Hori, Shingo
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (05) : 312 - 314
  • [3] An Evaluation of Hepatotoxicity and Nephrotoxicity of Liposomal Amphotericin B (L-AMB)
    Patel G.P.
    Crank C.W.
    Leikin J.B.
    Journal of Medical Toxicology, 2011, 7 (1) : 12 - 15
  • [4] Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children
    Sunakawa, Keisuke
    Tsukimoto, Ichiro
    Tsunematsu, Yukiko
    Honda, Masatada
    Iwai, Naoichi
    Maniwa, Takashi
    Haigo, Hisamatsu
    Suzuki, Kota
    Mori, Takeshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (04) : 456 - 465
  • [5] WEEKLY HIGH DOSE LIPOSOMAL AMPHOTERICIN B (L-AMB) IN SEPTIC SHOCK PATIENTS WITH MULTIPLE CANDIDA COLONIZATION: AMBIDEX STUDY
    Azoulay, E.
    Timsit, J-F
    Souweine, B.
    Legriel, S.
    Max, A.
    Misset, B.
    Cohen, Y.
    Wolff, M.
    INTENSIVE CARE MEDICINE, 2011, 37 : S123 - S123
  • [6] Comparison of the nephrotoxic and antigungal effects of amphotericin B-deoxycholate (D-AmB) and liposomal amphotericin B (L-AmB).
    Sabra, R
    Zeinoun, N
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R524 - R524
  • [7] Low dose liposomal amphotericin B (L-AmB) as prophylaxis of invasive fungal infections (IFI) in neutropenic patients (pts): Is it cost effective?
    Penack, Olaf
    Martus, Peter
    Thiel, Eckhard
    Blau, Igor W.
    BLOOD, 2006, 108 (11) : 948A - 949A
  • [8] Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study
    Azoulay, Elie
    Timsit, Jean-Francois
    Lautrette, Alexandre
    Legriel, Stephane
    Max, Adeline
    Ruckly, Stephane
    Misset, Benoit
    Cohen, Yves
    Wolff, Michel
    PLOS ONE, 2017, 12 (05):
  • [9] Retrospective comparison or lipid amphotericin B complex (ABLC) and liposomal amphotericin B (L-AMB) in the pediatric population.
    Sykes, RB
    Sahni, J
    Ellis, JM
    Kuti, JL
    PHARMACOTHERAPY, 2005, 25 (03): : 469 - 469
  • [10] COMPARATIVE NEPHROTOXICITY OF FREE AND LIPOSOMAL AMPHOTERICIN-B (AMB AND L-AMB) DURING CHRONIC ADMINISTRATION IN RATS
    LONQUET, P
    JOLY, V
    SETA, N
    FRIEDLANDER, G
    CARBON, C
    YENI, P
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 412 - 412
12345